Routine TP53 testing for breast cancer under age 30: ready for prime time? (Q47317433)

13 January 2018

title

Routine TP53 testing for breast cancer under age 30: ready for prime time? (English)

1 reference

13 January 2018

6

Steven A Narod

1 reference

13 January 2018

author name string

Jeanna M McCuaig

1

1 reference

13 January 2018

Susan R Armel

2

1 reference

13 January 2018

Ana Novokmet

3

1 reference

13 January 2018

Ophira M Ginsburg

4

1 reference

13 January 2018

Rochelle Demsky

5

1 reference

13 January 2018

David Malkin

7

1 reference

13 January 2018

publication date

1 December 2012

1 reference

13 January 2018

published in

Familial Cancer

1 reference

13 January 2018

volume

11

1 reference

13 January 2018

issue

4

1 reference

13 January 2018

page(s)

607-613

1 reference

13 January 2018

Familial breast cancer: collaborative reanalysis of individual data from 52 epidemiological studies including 58,209 women with breast cancer and 101,986 women without the disease

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS10689-012-9557-Z

Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10689-012-9557-Z

Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility: recommendation statement

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10689-012-9557-Z

Incidence and outcome of BRCA mutations in unselected patients with triple receptor-negative breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10689-012-9557-Z

A novel HER2-positive breast cancer phenotype arising from germline TP53 mutations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10689-012-9557-Z

Early onset HER2-positive breast cancer is associated with germline TP53 mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10689-012-9557-Z

Soft-tissue sarcomas, breast cancer, and other neoplasms. A familial syndrome?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10689-012-9557-Z

Spectrum of mutations in BRCA1, BRCA2, CHEK2, and TP53 in families at high risk of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10689-012-9557-Z

Beyond Li Fraumeni Syndrome: clinical characteristics of families with p53 germline mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10689-012-9557-Z

Population-based estimate of the contribution of TP53 mutations to subgroups of early-onset breast cancer: Australian Breast Cancer Family Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10689-012-9557-Z

The pathology of familial breast cancer: predictive value of immunohistochemical markers estrogen receptor, progesterone receptor, HER-2, and p53 in patients with mutations in BRCA1 and BRCA2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10689-012-9557-Z

Novel de novo BRCA2 mutation in a patient with a family history of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10689-012-9557-Z

Unique de novo mutation of BRCA2 in a woman with early onset breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10689-012-9557-Z

De novo BRCA1 mutation in a patient with breast cancer and an inherited BRCA2 mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10689-012-9557-Z

De novo recurrent germline mutation of the BRCA2 gene in a patient with early onset breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10689-012-9557-Z

Two metachronous tumors in the radiotherapy fields of a patient with Li-Fraumeni syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10689-012-9557-Z

Biochemical and imaging surveillance in germline TP53 mutation carriers with Li-Fraumeni syndrome: a prospective observational study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10689-012-9557-Z

Comparable frequency of BRCA1, BRCA2 and TP53 germline mutations in a multi-ethnic Asian cohort suggests TP53 screening should be offered together with BRCA1/2 screening to early-onset breast cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10689-012-9557-Z

Prediction of pathogenic mutations in patients with early-onset breast cancer by family history

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10689-012-9557-Z

Identification of a de novo BRCA1 mutation in a woman with early onset bilateral breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10689-012-9557-Z

TP53 germline mutation testing in 180 families suspected of Li-Fraumeni syndrome: mutation detection rate and relative frequency of cancers in different familial phenotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10689-012-9557-Z

Frequency of BRCA1/BRCA2 mutations in a population-based sample of young breast carcinoma cases

21 January 2018

1 reference

12 December 2020

The prevalence of germ-line TP53 mutations in women diagnosed with breast cancer before age 30

1 reference

12 December 2020

High frequency of de novo mutations in Li-Fraumeni syndrome

1 reference

12 December 2020

2009 Version of the Chompret Criteria for Li Fraumeni Syndrome

1 reference

12 December 2020

Prevalence and diversity of constitutional mutations in the p53 gene among 21 Li-Fraumeni families.

1 reference

12 December 2020

Germline mutations in the TP53 gene

1 reference

12 December 2020

Molecular basis of the Li-Fraumeni syndrome: an update from the French LFS families

1 reference

12 December 2020

Case report: de novo BRCA2 gene mutation in a 35-year-old woman with breast cancer

1 reference

12 December 2020

Joint effects of germ-line p53 mutation and sex on cancer risk in Li-Fraumeni syndrome

1 reference

12 December 2020

A cancer family syndrome in twenty-four kindreds

1 reference

12 December 2020

10.1007/S10689-012-9557-Z

Identifiers

DOI

1 reference

13 January 2018

1 reference

13 January 2018